Biotech

All Articles

Fierce Biotech Editor-in-Chief Ayla Ellison Chats Patronize Michelle Benz on the Future of Biotech.

.Let's dive into a discussion with Ayla Ellison, Tough Biotech Managing Editor and Michelle Benz as ...

New information demonstrate how Bayer's asundexian stopped working to avoid strokes

.Bayer suspended the period 3 trial for its factor XIa inhibitor asundexian behind time last year af...

Sanofi's tolebrutinib falls short 2 of 3 late-stage MS trials

.Sanofi is still set on taking its own a number of sclerosis (MS) med tolebrutinib to the FDA, execs...

Galapagos' stockpile as fund reveals intent to shape its own progression

.Galapagos is coming under additional tension from entrepreneurs. Having built a 9.9% stake in Galap...

Cell- concentrated Sana scoops very first CSO-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of notable leadership hirings, firings and ...

Allist settles Jacobio $21M, landing role in Mandarin KRAS race

.Shanghai Allist Pharmaceuticals has actually acquired itself a starring character in China's KRAS m...

ReNeuron leaving objective swap after missing fundraising goal

.ReNeuron has signed up with the long listing of biotechs to leave behind Greater london's purpose s...

MBX files for IPO to take opposition to Ascendis in to stage 3

.MBX Biosciences has included in the recent flurry of IPO filings. The biotech, which submitted its ...

FDA grows probing in to Lykos' MDMA trials: WSJ

.For Lykos Therapies as well as the business's prospective MDMA-assisted therapy for post-traumatic ...

Gene publisher Volume laying off 131 workers

.Only days after genetics publisher Volume Biosciences declared hidden functional slices, a more cle...